Early safety check for potential addiction treatment
NCT ID NCT06480981
Summary
This completed early-stage study tested how the body absorbs and processes a compound called noribogaine, and checked its safety. It involved 55 healthy adults who received either the compound or a placebo over eight days. The main goal was to gather basic information about how the drug behaves in the body to inform future research.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PHARMACOKINETICS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Richmond Pharmacology
London, United Kingdom
Conditions
Explore the condition pages connected to this study.